Stock Price
0.62
Daily Change
-0.04 -6.06%
Monthly
-8.15%
Yearly
604.55%
Q2 Forecast
0.61

Starpharma Holdings reported AUD-873K in Operating Profit for its fiscal semester ending in December of 2025.





Operating Profit Change Date
Medical Developments International AUD -36K 444K Dec/2025
Mesoblast USD -30.96M 11.14M Dec/2025
Neuren Pharmaceuticals AUD 17.01M 11.56M Dec/2025